EFTR - eFFECTOR Therapeutics, Inc.
Previous close
0.1891
-11.761 -6,219.408%
Share volume: 0
Last Updated: Tue 02 Jul 2024 08:03:49 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$11.95
-11.76
-98.42%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-10 | 2022-08-09 | 2022-11-07 | 2023-03-08 | 2023-05-09 | 2023-08-08 | 2023-11-13 | |
| Total revenue | 0.000 | 2.011 M | 867.000 K | 675.000 K | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 2.011 M | 867.000 K | 675.000 K | 0.000 | 0.000 | 0.000 | |
| inf% | -56.89% | -22.15% | -100.00% | nan% | nan% | |||
| Operating expenses | 6.548 M | 9.892 M | 10.118 M | 9.398 M | 9.536 M | 7.855 M | 7.855 M | |
| Selling general and admin | 3.436 M | 2.973 M | 3.486 M | 2.748 M | 2.927 M | 2.974 M | 2.500 M | |
| Research and development | 3.112 M | 6.919 M | 6.632 M | 6.650 M | 6.609 M | 4.881 M | 5.355 M | |
| Total expenses | 6.548 M | 9.892 M | 10.118 M | 9.398 M | 9.536 M | 7.855 M | 7.855 M | |
| 51.07% | 2.28% | -7.12% | 1.47% | -17.63% | 0.00% | |||
| Operating income | -6.548 M | -7.881 M | -9.251 M | -8.723 M | -9.536 M | -7.855 M | -7.855 M | |
| Ebit | -6.548 M | -7.881 M | -9.251 M | -8.723 M | -9.536 M | -7.855 M | -7.855 M | |
| Pretax income | 3.069 M | -6.915 M | -9.559 M | -9.260 M | -10.014 M | -8.364 M | -8.303 M | |
| -325.32% | 38.24% | -3.13% | 8.14% | -16.48% | -0.73% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 3.069 M | -6.915 M | -9.559 M | -9.260 M | -10.014 M | -8.364 M | -8.303 M | |
| -325.32% | -38.24% | 3.13% | -8.14% | 16.48% | 0.73% | |||
| Net income | 3.069 M | -6.915 M | -9.559 M | -9.260 M | -10.014 M | -8.364 M | -8.303 M | |
| -325.32% | -38.24% | 3.13% | -8.14% | 16.48% | 0.73% |